US Patent Issued on July 28 for "Fixed dose oral testosterone undecanoate compositions and use thereof" (Utah Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,057, issued on July 28.

"Fixed dose oral testosterone undecanoate compositions and use thereof" was invented by Mahesh V. Patel (Salt Lake City), Nachiappan Chidambaram (Salt Lake City) and Kilyoung Kim (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are effective fixed dose oral testosterone undecanoate compositions for use in regimens without dose titration and methods for treatment of patients in need of testosterone replacement therapy. Also disclosed are criteria for continuation and discontinuation of such regimens, based on single serum T concentration levels measured at a steady state at predetermined times after ini...